You are here

Injectable Foam to Staunch Bleeding is Breakthrough Therapy

Lifesaving Life Foam for Battlefield, Terrorist Attacks, Trauma

Life Foam™, an expanding, internal-use injectable hemostat, designed by gel-e Inc., has received a breakthrough status designation from the FDA.

Life Foam provides rapid, temporary control of bleeding from non-compressible abdominal wounds that do not lend themselves to tourniquet application during trauma and battlefield conditions. The product is designed to save the lives of those injured in battle, or who are victims of traumatic accidents or terrorist attacks.

Trauma from accidents is the third leading cause of death in the U.S. after heart disease and cancer. Approximately 85% of all hemorrhage-related deaths arise from non-compressible internal bleeding––intracavitary (e.g., abdominal) bleeding that is not accessible to direct pressure and cannot be controlled by typical methods such as gauze or a tourniquet.

When it is delivered into the abdominal cavity, Life Foam expands dramatically, seeking out the bleeding source in the patient for quick and efficient stabilization. This enables the injured person to be safely transported to a trained trauma surgeon, who can repair the damage in a controlled surgical environment.

The foam is currently in preclinical development for treating patients who have been injured in battlefield conditions or where life-threatening internal bleeding occurs in a location away from immediate urgent care.

Source: BioSpace, June 18, 2019

Recent Headlines

Two-Thirds of U.S. Alzheimer’s Cases Are Women, And It’s Not Just Because They Live Longer
Recarbrio Should be Reserved For Limited/No Alternative Antibacterial Treatment Cases
Breast Cancer, Gastrointestinal Tumors Most Common Types
NY Hospitals Required to Implement Protocols in Suspected Cases
Presence of BOK Protein Key for Positive Treatment Response
Patient Access to Inhaler Use Data Could Improve Asthma Management
Attacks Cancerous Cells, Leaves Healthy Tissues Alone